Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 588-593

  Strand, Susanne ^a   Hofmann, Walter J ^b   Grambihler, Annette ^a   Hug, Hubert ^c   Volkmann, Martin ^a   Otto, Gerd ^d   Wesch, Horst ^f   Mariani, Sara M ^e   Hack, Volker ^g   Stremmel, Wolfgang ^a   Krammer, Peter H ^e   Galle, Peter R ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Institute of Pathology   (Germany)

^c Center for Molecular Biology   (Germany)

^d Department of Surgery ^*  (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f Radiology Program   (Germany)

^g Division of Immunochemistry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; FAS ANTIGEN; MESSENGER RNA;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CASE REPORT; CELL STRAIN HEPG2; CONTROLLED STUDY; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL DAMAGE; LIVER FAILURE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WILSON DISEASE;

ACUTE DISEASE; ANTIGENS, CD95; APOPTOSIS; COPPER; FAS LIGAND PROTEIN; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; MEMBRANE GLYCOPROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17344387813     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-588     Document Type: Article

References (42)

1. Sternlieb, I. Copper and the liver. Gastroenterology 78, 1615-1628 (1980).
2. Danks, D.M. Disorders of copper transport. In: The Metabolic Basis of Inherited Disease. Eds: Scriver C.R., Beaudet A.L., Sly W.S., Valle D. Mc Graw-Hill, 7th edition, New York 1995;-4125-4158.
3. Scheinberg, I.H. & Sternlieb, I. Wilson's disease. In: Major problems in internal medicine (Ed. Smith L.H.) 1-179 (Saunders, Philadelphia 1984).
4. Popper, H., Goldfischer, S., Sternlieb I., Nayak, N.B. & Madhaven, T.V. Cytoplasmatic copper and its toxic effects - studies in Indian childhood cirrhosis. Lancet 1: 1205-1208 (1979).
5. Lefkowitch, J.H., Honig, C.L., King, M.E. & Hagstrom, J.W.C. Hepatic copper overload and features of Indian childhood cirrhosis in an American sibship. N. Engl. J. Med. 307, 271-277 (1982).
6. Pimentel, J.C. & Menezes, A.P. Liver granulomas containing copper in vineyard sprayer's lung: a new etiology of hepatic granulomatosis. Am. Rev. Respir. Dis. 111, 189-195 (1975).
7. Bull, P.C., Thomas, G.R., Rommens, J.M., Forbes, J.R. & Cox, D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet. 5, 327-337 (1993).
8. Tanzi, R.E. et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet. 5, 344-350 (1993).
9. Stremmel, W. et al. Wilson disease; Clinical presentation, treatment, and survival. Annals Internal. Med. 115, 720-726 (1991).
10. O'Grady, J.G., Portmann, B. & Williams, R. Fulminant hepatic failure. In: Diseases of the Liver. Schiff L. and Schiff E.R., eds. 7th edition, 1078-1079 (1993).
11. Aust, S.D., Morehouse, L.A. & Thomas, C.E. Role of metals in oxygen radical reactions. Free Rad. Bio. Med. 1, 3-25 (1985).
12. Hochstein, P., Kumar, S. & Forman, S.J. Lipid peroxidation and the cytotoxicity of copper. Ann .NY Acad. Sci. 355, 240-248 (1980).
13. Vierling, J.M. Copper metabolism in primary biliary cirrhosis. Semin. Liver Dis. 1, 293-308 (1981).
14. Buttke, T.M. & Sandstrom, P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today 15, 7-10 (1994).
15. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989).
16. Yonehara, S., Ishii, A. & Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756 (1989).
17. Itoh, N. et al. The polypepetide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243 (1991).
18. Oehm, A. et al. Purification and molecular cloning of the APO-1 surface antigen, a member of the TNF/NGF receptor superfamily. J. Biol. Chem. 267, 10709-10715 (1992).
19. Suda, T. & Nagata, S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873-879 (1994).
20. Leithäuser, F. et al. Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429 (1993).
21. Strand, S. et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells - A mechanism of immune evasion? Nature Med. 2, 1361-1367 (1996).
22. Galle, P.R. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182,: 1223-1230 (1995).
23. Müller, M. et al. Drug-induced apoptosis in hepatoma cells involves activation of p53 and is mediated by the CD95 (APO-1/Fas) receptor/ligand system. J. Clin. Invest. 99, 403-413 (1997).
24. Benedetti, A.A., Jezaquel, M. & Orlandi, F. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J. Hepat. 7, 319-324 (1988).
25. Ray, S.D., Mumaw, V.R., Raje, R.R. & Fariss, M.W. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J. Pharmaco. Exp. Ther. 279, 1470-83 (1996).
26. Patel, T., Bronk, S. & Gores, G.J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J. Clin. Invest. 94, 2183-2192 (1994).
27. Wolfe, J.T., Ross, D. & Cohen, G.M. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Letters 352, 58-62 (1994).
28. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809 (1993).
29. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
30. Owen-Schaub, L.B. et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15, 3032-3040 (1995).
31. Hug, H. et al. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem., 1997,-28191-28193.
32. Harrison, P.M., Wendon, J.A., Gimson, A.E., Alexander, G.J. & Williams, R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med. 324, 1852-57 (1991).
33. Kondo, T. et al. Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3, 409-413 (1997).
34. Dhein, J et al. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149, 3166-3173 (1992).
35. Lau, S.J., Kruck, T.P. & Sarkar, B. A peptide molecule mimicking the copper(II) transport site of human serum albumin. A comparative study between the synthetic site and albumin. J. Biol. Chem. 249, 5878-84 (1974).
36. Eck, H.-P., Gmünder, H., Hartmann, M. & Petzhold, D. Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol. Chem. Hoppe-Seyler 370, 101-108 (1989).
37. Wesch, H. & Bindl, A. Analysis of 11 elements in biological material. NBS Special Publication 422, held October 7-11.-1974, Gaithersburg.
38. Peter, M.E. et al. APO-1 (CD95)-dependent and-independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7, 1873-1877 (1995).
39. Mariani, S.M., Matiba, B., Bäumler, C. & Krammer, P. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303-2307 (1995).
40. Nicoletti, I., Migliorati, G., Paggliacci, M.C., Grignani, F. & Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth. 139, 271-279 (1991).
41. Sellins, K.S. & Cohen, J.J. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. Immunol. 139, 3199-3206 (1987).
42. Volkmann, M. et al. P53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the Codon 249 hot spot mutation. Oncogene 9, 195-204 (1994).